NEW YORK (GenomeWeb News) - Stephane Perrey will serve as president of Qiagen KK, Qiagen's Tokyo subsidiary. He is taking over for Kazuo Tokushige, who retired on Dec. 31. Perrey formerly worked at Third Wave/Hologic Japan and he held various positions in Japan's in vitro diagnostic industry.
Allen Bombard has accepted the job of chief medical officer at Sequenom. In the role, Bombard will oversee the company's clinical and medical affairs.
Formerly, Bombard was CEO at Lenetix, CMO at Sharp Mary Birch Hospital in San Diego, and he was senior VP and director of the residency program in obstetrics and gynecology at Lutheran Medical Center in Brooklyn, NY. He also has served as a medical director for women's health at Aetna, and he was director of the Department of Obstetrics and Gynecology and Women's Health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, NY.
Biosearch Technologies has named Jerry Ruth director of R&D, Chad Gerber director of IVD oligonucleotide manufacturing, and Adam Mazzo quality systems manager. Ruth previously was VP of R&D at Molecular Biosystems, director of genomics and proteomics at Molecular Probes, and he worked in DNA forensics for the US Fish and Wildlife Services. Gerber previously worked at Third Wave Technologies as director of manufacturing, and Mazzo was in quality assurance at Lonza Biologics.
DxS has tapped Jeff Devlin to be chief operating officer. Devlin previously was executive VP and executive committee member at Shire Pharmaceuticals, and he was a partner in Ernst and Young's life science division.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected].com to appear in PEOPLE, a weekly roundup of industry comings and goings.